AZN

U.S. FDA approves orphan drug MyaleptTM (metreleptin for injection)

[Business Wire] – AstraZeneca today announced that the U.S. Food and Drug Administration has approved Myaleptâ„¢ , which is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring […]

AstraZeneca Patient Assistance Programs Provided More Than Half a Million Patients with Free Medicine in 2013

[Business Wire] – AstraZeneca announced today that, in 2013, it provided nearly $975 million in savings to more than 567,000 patients in the United States through its patient assistance programs. moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

Markets today: 5 things you may have missed

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

Can AstraZeneca plc Make £5 Billion Profit?

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

FTSE rally stalls, robust profits boost Sports Direct

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

Is AstraZeneca plc Dependent On Debt?

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]